Bausch + Lomb previewed a forthcoming product and pointed to company-funded research showing treatment effects possible after two, four and eight weeks of daily use.
Most rely on artificial tears more so than eyelid-based interventions, 22% spend an hour or more daily on care and less than half reported that their primary source of information is their eyecare provider.
OCT imaging—performed with longer wavelengths—captured a greater percentage of these structures. Researchers wonder if the distinction may impact clinical management decisions.